Protalix Biotherapeutics Inc (PLX) — Free Cash Flow Generation Index
Protalix Biotherapeutics Inc (PLX) has a Free Cash Flow Generation Index of 1.61x as of December 2025. Free cash flow of $3.27 Million represents 2% of operating cash flow ($2.03 Million). Explore PLX capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Protalix Biotherapeutics Inc Free Cash Flow Generation Index (2009–2024)
Historical FCF Generation Index trend for Protalix Biotherapeutics Inc across 3 annual periods. For the full cash flow conversion analysis, see Protalix Biotherapeutics Inc cash conversion from operations.
Annual Free Cash Flow Generation for Protalix Biotherapeutics Inc (2009–2024)
Year-by-year Free Cash Flow Generation Index for Protalix Biotherapeutics Inc. Check how aggressively does Protalix Biotherapeutics Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.85x | $7.39 Million | $8.67 Million | $1.28 Million | ▲ +137.8% |
| 2012 | -2.26x | $-1.43 Million | $635.00K | $2.07 Million | ▼ -362.2% |
| 2009 | 0.86x | $38.26 Million | $44.45 Million | $6.20 Million | — |